Close

National Institute for Health and Care Excellence (NICE) Issues Medtech Innovation Briefing on CytoSorb for Reducing Risk of Bleeding During Cardiac Surgery

Go back to National Institute for Health and Care Excellence (NICE) Issues Medtech Innovation Briefing on CytoSorb for Reducing Risk of Bleeding During Cardiac Surgery
Cytosorbents Corporation (NASDAQ: CTSO) Delayed: 0.95 +0.02 (2.15%)
Previous Close $0.93    52 Week High $7.48 
Open $0.91    52 Week Low $3.11 
Day High $0.96    P/E N/A 
Day Low $0.94    EPS $-0.03 
Volume 116,409